|CompTox Dashboard (EPA)|
|Chemical and physical data|
|Molar mass||649.65 g·mol−1|
|3D model (JSmol)|
|(what is this?)|
Avatrombopag is a medication that used for certain conditions that lead to thrombocytopenia (low platelets) such as thrombocytopenia associated with chronic liver disease in adult patients who are to undergo a planned medical or dental procedure. It was approved for medical use in the United States in 2018.
- FDA approves new drug for patients with chronic liver disease who have low blood platelets and are undergoing a medical procedure
|This drug article relating to the blood and blood forming organs is a stub. You can help Wikipedia by expanding it.|